000			02258cam a22003854a 4500
999			_c1931 _d1931
001			15681732
003			SUN
005			20180720095433.0
008			090330s2009 nyu b 001 0 eng
010			_a 2009013524
016	7		_a101500490 _2DNLM
020			_a9781607415930 (hardcover : alk. paper)
020			_a1607415933 (hardcover : alk. paper)
035			_a(OCoLC)ocn317664305
040			_aDNLM/DLC _cSUNLIB _dNLM _dBTCTA _dC#P _dYDXCP _dDLC
042			_apcc
050	0	0	_aRC280.B8 _bL2715 2009
082	0	0	_a362.19699449/ _222 _bLAC
100	1		_aLacroix, Marc, _d1963- _94025
245	1	0	_aMolecular therapy of breast cancer : _bclassicism meets modernity / _cMarc Lacroix.
260			_aNew York : _bNova Biomedical Books, _cc2009.
300			_aviii, 291 p. ; _c27 cm.
490	1		_aCancer etiology, diagnosis and treatments series
504			_aIncludes bibliographical references and index.
505	0		_aIntroduction -- Selective estrogen receptor modulators (SERMs) and down-regulators (SERDs) -- Aromatase inhibitors -- Agents inducing ovarian suppression -- Antimetabolites -- Alkylating agents -- Anthracyclines -- Microtubule-binding agents -- Topoisomerase inhibitors -- HER family inhibitors -- Angiogenesis inhibitors -- Insulin-like growth factor-I receptor (IGF-1R) inhibitors -- Ras-Raf-MEK-ERK pathway inhibitors -- Ubiquitin-proteasome system inhibitors -- Histone deacetylases inhibitors -- Mitotic inhibitors -- Inhibitors of heat-shock proteins 90 and 27 -- PI3K/Akt/mTOR pathway inhibitors -- Cyclooxygenase-2 inhibitors -- Poly(ADP-Ribose) polymerase (PARP)-1 inhibitors -- Tumor-induced osteolysis inhibitors -- Vaccines and immunomodulators -- Varia.
650		0	_aBreast _xCancer _xMolecular aspects. _94026
650		0	_aAntineoplastic agents. _94027
650	1	2	_aBreast Neoplasms _xdrug therapy. _94028
650	2	2	_aAntineoplastic Agents _xtherapeutic use. _94029
650	2	2	_aEnzyme Inhibitors _xtherapeutic use. _94030
830		0	_aCancer etiology, diagnosis, and treatments. _94031
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cBK